Nutex Health Inc

Company Profile

Nutex Health Inc had its IPO on 2022-04-04 under the ticker symbol NUTX.

The company operates in the Healthcare sector and Health Information Services industry. Nutex Health Inc has a staff strength of 800 employees.

Stock update

Shares of Nutex Health Inc opened at $0.26 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.22 - $0.26, and closed at $0.22.

This is a -14.79% slip from the previous day's closing price.

A total volume of 5,179,948 shares were traded at the close of the day’s session.

In the last one week, shares of Nutex Health Inc have slipped by -20.94%.

Nutex Health Inc's Key Ratios

Nutex Health Inc has a market cap of $183.35 million, indicating a price to book ratio of 11.3505 and a price to sales ratio of 3.0035.

In the last 12-months Nutex Health Inc’s revenue was $197.37 million with a gross profit of $36.30 million and an EBITDA of $-32270302. The EBITDA ratio measures Nutex Health Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Nutex Health Inc’s operating margin was -20.73% while its return on assets stood at -3.91% with a return of equity of -131.85%.

In Q2, Nutex Health Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 1.5%.

Nutex Health Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.61 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Nutex Health Inc’s profitability.

Nutex Health Inc stock is trading at a EV to sales ratio of 3.9689 and a EV to EBITDA ratio of 6.4575. Its price to sales ratio in the trailing 12-months stood at 3.0035.

Nutex Health Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$436.23 million

Total Liabilities

$57.44 million

Operating Cash Flow

$-3069919.00

Capital Expenditure

$3.07 million

Dividend Payout Ratio

0%

Nutex Health Inc ended 2024 with $436.23 million in total assets and $0 in total liabilities. Its intangible assets were valued at $436.23 million while shareholder equity stood at $92.62 million.

Nutex Health Inc ended 2024 with $0 in deferred long-term liabilities, $57.44 million in other current liabilities, 660742.00 in common stock, $-371912251.00 in retained earnings and $17.01 million in goodwill. Its cash balance stood at $32.75 million and cash and short-term investments were $32.75 million. The company’s total short-term debt was $25,050,338 while long-term debt stood at $25.11 million.

Nutex Health Inc’s total current assets stands at $92.08 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $52.01 million compared to accounts payable of $20.34 million and inventory worth $2.45 million.

In 2024, Nutex Health Inc's operating cash flow was $-3069919.00 while its capital expenditure stood at $3.07 million.

Comparatively, Nutex Health Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.22

52-Week High

$2.73

52-Week Low

$0.2151

Analyst Target Price

$2.75

Nutex Health Inc stock is currently trading at $0.22 per share. It touched a 52-week high of $2.73 and a 52-week low of $2.73. Analysts tracking the stock have a 12-month average target price of $2.75.

Its 50-day moving average was $0.35 and 200-day moving average was $0.93 The short ratio stood at 2.24 indicating a short percent outstanding of 0%.

Around 4952.3% of the company’s stock are held by insiders while 634.7% are held by institutions.